| Dr Jhon M Nogales Pimienta, MD | |
|
5165 Mccarty Ln, Lafayette, IN 47905-8764 | |
| (765) 838-7101 | |
| Not Available |
| Full Name | Dr Jhon M Nogales Pimienta |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 5165 Mccarty Ln, Lafayette, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114583762 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101275350 (Virginia) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Oxford BioMedica, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.
WHO welcomes the announcement from the Bill and Melinda Gates Foundation and the Bloomberg Philanthropies to inject significant new resources into the global fight against tobacco use.
BDI Pharma today announced the launch of The MERREM Commitment Program with AstraZeneca, an assurance initiative offering customers security in product availability through contracted access to the original, branded MERREM I.V. from AstraZeneca.
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice to consumers and the herbal sector about the poor quality of some traditional chinese medicines (TCMs) on the UK market.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jhon M Nogales Pimienta, MD 5165 Mccarty Ln, Lafayette, IN 47905-8764 Ph: (765) 838-7101 | Dr Jhon M Nogales Pimienta, MD 5165 Mccarty Ln, Lafayette, IN 47905-8764 Ph: (765) 838-7101 |
News Archive
Oxford BioMedica, a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin for the treatment of Parkinson's disease were presented at the American Society of Gene & Cell Therapy 14th Annual Meeting held in Seattle, USA by Professor Stephane Palfi, Principal Investigator at the Henri Mondor Hospital in Paris, on Saturday 21 May 2011.
WHO welcomes the announcement from the Bill and Melinda Gates Foundation and the Bloomberg Philanthropies to inject significant new resources into the global fight against tobacco use.
BDI Pharma today announced the launch of The MERREM Commitment Program with AstraZeneca, an assurance initiative offering customers security in product availability through contracted access to the original, branded MERREM I.V. from AstraZeneca.
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued advice to consumers and the herbal sector about the poor quality of some traditional chinese medicines (TCMs) on the UK market.
› Verified 2 days ago